Savić Vedrana, Todosijević Marija, Ilić Tanja, Lukić Milica, Mitsou Evgenia, Papadimitriou Vassiliki, Avramiotis Spyridon, Marković Bojan, Cekić Nebojša, Savić Snežana
Department of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.
Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, Athens, Greece.
Int J Pharm. 2017 Aug 30;529(1-2):491-505. doi: 10.1016/j.ijpharm.2017.07.036. Epub 2017 Jul 12.
In order to improve skin penetration of tacrolimus we aimed to develop potentially non-irritant, lecithin-based microemulsions containing ethanol, isopropanol and/or propylene glycol as cosurfactants, varying caprylic/capric triglycerides and propylene glycol monocaprylate as oil phase. The influence of excipients on the size of microemulsion region in pseudo-ternary phase diagrams and their ability to form different types of microemulsions was evaluated. The comprehensive physicochemical characterization of microemulsions and the evaluation of their structure was performed, while the localization of tacrolimus in microemulsions was further investigated using electron paramagnetic resonance spectroscopy. Moreover, stability studies proved no change in tacrolimus content during one year of storage at room temperature. In addition, in vivo skin performance indicated no skin irritation potential of blank microemulsions, whereas in vitro release testing using Franz diffusion cells showed superior release rate of tacrolimus from microemulsions (0.98±0.10 and 0.92±0.11μg/cm/h for two bicontinuous and 1.00±0.24μg/cm/h for oil-in-water microemulsion) compared to referent Protopic ointment (0.15±0.08μg/cm/h). Furthermore, ex vivo penetration assessed through porcine ear skin using tape stripping, confirmed superiority of two microemulsions related to the reference, implying developed microemulsions as promising carriers for dermal delivery of tacrolimus.
为了提高他克莫司的皮肤渗透性,我们旨在开发潜在无刺激性、以卵磷脂为基础的微乳剂,其含有乙醇、异丙醇和/或丙二醇作为助表面活性剂,以不同比例的辛酸/癸酸甘油三酯和单辛酸丙二醇酯作为油相。评估了辅料对伪三元相图中微乳区域大小的影响及其形成不同类型微乳的能力。对微乳剂进行了全面的物理化学表征并评估了其结构,同时使用电子顺磁共振光谱进一步研究了他克莫司在微乳剂中的定位。此外,稳定性研究证明在室温下储存一年期间他克莫司含量没有变化。另外,体内皮肤性能表明空白微乳剂没有皮肤刺激潜力,而使用Franz扩散池进行的体外释放测试表明,与对照普特彼软膏(0.15±0.08μg/cm/h)相比,他克莫司从微乳剂中的释放速率更高(两种双连续微乳剂分别为0.98±0.10和0.92±0.11μg/cm/h,水包油型微乳剂为1.00±0.24μg/cm/h)。此外,通过猪耳皮肤胶带剥离法进行的离体渗透评估证实了两种微乳剂相对于对照的优越性,这意味着所开发的微乳剂有望成为他克莫司经皮给药的载体。